27 results
Medications for Treatment of Acute Gout
 - NSAIDs
 - Colchicine (Colcrys)
 - Corticosteroids
#Acute #Gout #Medications #Treatment
Medications for ... #Acute #Gout #Medications ... #Treatment #Management ... #AAFP #Rheumatology
Medications for Prevention of Chronic Gout
Colchicine (Colcrys)
Pegloticase (Krystexxa)
Probenecid
Xanthine oxidase inhibitors:
 - Allopurinol (Zyloprim)
 - Febuxostat (Uloric)
#Chronic
Medications for ... Chronic #Gout #Medications ... #Treatment #Management ... #AAFP #Rheumatology
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Perioperative Management ... Antirheumatic Medication ... MithuRheum #rheumatology ... #medications #hold ... perioperative #guidelines #management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... pharmacology #treatment #medications ... decisionaid #cardiology #hematology
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
Anticoagulant Medications ... Summary #table #comparison ... #diagnosis #hematology
Consensus Indications for Irradiated RBC Transfusions:

Cellular blood components are irradiated for the prevention of TA-GVHD. Transfused
Consensus Indications ... #Transfusion #Indications ... #Hematology #BloodBank ... #Management
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
200ng/mL Best indications ... Measurement #SLE #rheumatology ... levels #lupus #management
Approach to Gout
Diagnosis: r/o septic arthritis! Needle-shaped, negative birefringent crystals
Treatment:
 • Weight loss, diet, d/c culprit
diet, d/c culprit medications ... gout #diagnosis #management ... treatment #ULT #rheumatology
What complications should we be aware of with common chemotherapy agents for hematologic malignancies?

Source: Scholes, Melissa
chemotherapy agents for hematologic ... #management #medications ... complications #hematology
JAK Inhibitors in 2019

Role in the therapeutic strategy in 2019
 • RA: 2nd line after failure
JAKInhibitors #Indications ... #Rheumatology # ... Management